These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31539229)

  • 1. Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.
    Zhou Y; Elmes MW; Sweeney JM; Joseph OM; Che J; Hsu HC; Li H; Deutsch DG; Ojima I; Kaczocha M; Rizzo RC
    Biochemistry; 2019 Oct; 58(42):4304-4316. PubMed ID: 31539229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.
    Hsu HC; Tong S; Zhou Y; Elmes MW; Yan S; Kaczocha M; Deutsch DG; Rizzo RC; Ojima I; Li H
    Biochemistry; 2017 Jul; 56(27):3454-3462. PubMed ID: 28632393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.
    Yan S; Elmes MW; Tong S; Hu K; Awwa M; Teng GYH; Jing Y; Freitag M; Gan Q; Clement T; Wei L; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Wang L; Bogdan DM; Falcone J; Smietalo N; Zhou Y; Ralph B; Hsu HC; Li H; Rizzo RC; Deutsch DG; Kaczocha M; Ojima I
    Eur J Med Chem; 2018 Jun; 154():233-252. PubMed ID: 29803996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
    Al-Jameel W; Gou X; Forootan SS; Al Fayi MS; Rudland PS; Forootan FS; Zhang J; Cornford PA; Hussain SA; Ke Y
    Oncotarget; 2017 May; 8(19):31041-31056. PubMed ID: 28415688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into ligand binding features of dual FABP4/5 inhibitors by molecular dynamics simulations.
    Wu W; Han L; Wang C; Wen X; Sun H; Yuan H
    J Biomol Struct Dyn; 2019 Nov; 37(18):4790-4800. PubMed ID: 30590992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents.
    Wang H; Taouil A; Awwa M; Clement T; Zhu C; Kim J; Rendina D; Jayanetti K; Maharaj A; Wang L; Bogdan D; Pepe A; Kaczocha M; Ojima I
    Bioorg Chem; 2022 Dec; 129():106184. PubMed ID: 36244323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.
    Zhou Y; Nie T; Zhang Y; Song M; Li K; Ding M; Ding K; Wu D; Xu Y
    Bioorg Med Chem; 2016 Sep; 24(18):4310-4317. PubMed ID: 27460668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses.
    Chen J; Liu X; Zhang S; Chen J; Sun H; Zhang L; Zhang Q
    Phys Chem Chem Phys; 2020 Jan; 22(4):2262-2275. PubMed ID: 31917380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of novel rho kinase inhibitors using energy based pharmacophore modeling, shape-based screening, in silico virtual screening, and biological evaluation.
    Mishra RK; Alokam R; Singhal SM; Srivathsav G; Sriram D; Kaushik-Basu N; Manvar D; Yogeeswari P
    J Chem Inf Model; 2014 Oct; 54(10):2876-86. PubMed ID: 25254429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.
    Cai H; Liu Q; Gao D; Wang T; Chen T; Yan G; Chen K; Xu Y; Wang H; Li Y; Zhu W
    Eur J Med Chem; 2015 Jan; 90():241-50. PubMed ID: 25461324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors.
    Cai H; Wang T; Yang Z; Xu Z; Wang G; Wang HY; Zhu W; Chen K
    J Chem Inf Model; 2017 Sep; 57(9):2329-2335. PubMed ID: 28810126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.
    Halim SA; Sikandari AG; Khan A; Wadood A; Fatmi MQ; Csuk R; Al-Harrasi A
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening.
    Wang Y; Law WK; Hu JS; Lin HQ; Ip TM; Wan DC
    J Chem Inf Model; 2014 Nov; 54(11):3046-50. PubMed ID: 25360897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations.
    Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X
    PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand efficiency based approach for efficient virtual screening of compound libraries.
    Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
    Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold-focused virtual screening: prospective application to the discovery of TTK inhibitors.
    Langdon SR; Westwood IM; van Montfort RL; Brown N; Blagg J
    J Chem Inf Model; 2013 May; 53(5):1100-12. PubMed ID: 23672464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.
    Cai H; Yan G; Zhang X; Gorbenko O; Wang H; Zhu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3675-9. PubMed ID: 20471252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.